Travere Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
News > Health News
Audio By Carbonatix
1:30 PM on Monday, January 5
The Associated Press
SAN DIEGO--(BUSINESS WIRE)--Jan 5, 2026--
Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Eric Dube, Ph.D., president and chief executive officer, will present at the 44 th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 4:30 p.m. PT.
A live webcast of the presentation will be accessible on the Investor page of Travere’s website at ir.travere.com/events-presentations, and a replay will be available for up to 30 days following the event.
About Travere Therapeutics
At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20260105406739/en/
CONTACT: Investors:
888-969-7879
888-969-7879
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA
INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH SCIENCE PHARMACEUTICAL RESEARCH
SOURCE: Travere Therapeutics, Inc.
Copyright Business Wire 2026.
PUB: 01/05/2026 04:30 PM/DISC: 01/05/2026 04:30 PM
http://www.businesswire.com/news/home/20260105406739/en
